About Avacta
Avacta is a company based in Wetherby (United Kingdom) founded in 2003.. Avacta has completed 2 acquisitions, including CorisBio and Launch Diagnostics. Avacta operates in a competitive market with competitors including Jazz Pharmaceuticals, Revolution Medicines, Blueprint Medicines, Syndax and C4 Therapeutics, among others.
- Headquarter Wetherby, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Avacta Group Plc
-
Annual Revenue
$141.58 K (USD)-96.04as on Dec 31, 2024
-
Net Profit
$-66.2 M (USD)-58.89as on Dec 31, 2024
-
EBITDA
$-37.79 M (USD)-45.62as on Dec 31, 2024
-
Latest Funding Round
$4.39 M (USD), Post-IPO
Aug 29, 2025
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
CorisBio
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Avacta
Avacta is a publicly listed company on the LSE with ticker symbol AVCT in UK, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Avacta
- Total Funding Total Funding
- Total Rounds 12
- Last Round Post-IPO — $4.4M
-
First Round
First Round
(12 Jan 2011)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Post-IPO - Avacta | Valuation |
investors |
|
| Feb, 2024 | Amount | Post-IPO - Avacta | Valuation |
investors |
|
| Nov, 2022 | Amount | Post-IPO - Avacta | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Avacta
Avacta has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Medical Research Council. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Medical research is conducted to advance human health improvements.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Avacta
Avacta has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CorisBio and Launch Diagnostics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Rapid diagnostic tests for infectious diseases are developed and commercialized.
|
1996 | ||||
|
High-quality diagnostic reagents and instruments are supplied to healthcare providers.
|
1990 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Avacta
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Avacta Comparisons
Competitors of Avacta
Avacta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Revolution Medicines, Blueprint Medicines, Syndax and C4 Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
Selective kinase inhibitors are developed for genomically defined cancers.
|
|
| domain | founded_year | HQ Location |
Targeted therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Avacta
Frequently Asked Questions about Avacta
When was Avacta founded?
Avacta was founded in 2003 and raised its 1st funding round 8 years after it was founded.
Where is Avacta located?
Avacta is headquartered in Wetherby, United Kingdom. It is registered at Wetherby, West Yorkshire, United Kingdom.
What is the annual revenue of Avacta?
Annual revenue of Avacta is $141.58K as on Dec 31, 2024.
What does Avacta do?
Avacta was founded in 2003 and is based in Wetherby, United Kingdom. Operations focus on the biotechnology sector, where immunotherapies are developed by combining Affimer biotherapeutics with precision tumor-targeted chemotherapy. Diagnostics for cancer treatment are also advanced. The lead candidate, AVA6000, represents a tumor-targeted version of doxorubicin. Activities center on oncology solutions through these integrated platforms.
Who are the top competitors of Avacta?
Avacta's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and argenx.
Is Avacta publicly traded?
Yes, Avacta is publicly traded on LSE under the ticker symbol AVCT.
How many acquisitions has Avacta made?
Avacta has made 2 acquisitions, including CorisBio, and Launch Diagnostics.
Who are Avacta's investors?
Avacta has 1 investor. Key investors include Medical Research Council.
What is Avacta's ticker symbol?
The ticker symbol of Avacta is AVCT on LSE.